Printer Friendly

BIOMEDICAL WASTE SYSTEMS OPENS FIRST PROCESSING FACILITY; USING PROPRIETARY CFA TECHNOLOGY; ALSO ANNOUNCES ALLOWANCE OF PATENT

 BOSTON, July 15 /PRNewswire/ -- BioMedical Waste Systems Inc. (NASDAQ: BWSI) announced today it has opened its first regional medical- waste processing facility in Chelsea, Mass. The facility uses BioMed's proprietary CFA disinfection technology and a plastics recycling technology and is authorized to receive up to 75 tons of infectious waste per day. BioMed also announced that it has been informed by the United States Patent Office that the application for a patent on the CFA technology has been allowed.
 "This plant brings to fruition a two-year development process to position BioMed as a leading provider of low-cost medical waste management," BioMed President and Chief Executive Officer Gene Frisco said. "We are creating an integrated medical waste processing system that will ultimately include not only the treatment of medical waste and recovery of plastic, but also the manufacture of valuable products. The successful development of the Chelsea facility is a major turning point for our company and our industry. In addition, the patent allowance represents an assurance of long-term value for our shareholders."
 Integrated Process and Strategic Location:
 Frisco continued, "This plant, as well as the anticipated opening of our Chester, Pa., steam autoclave facility, will significantly reduce BioMed's dependence on third-party owned facilities and will cut costs by lessening the distance BioMed's East Coast collection companies travel to dispose of waste. Strategically located processing centers also are anticipated for the Minneapolis metro area as well as planned for New York and the San Francisco Bay area."
 How Chelsea Works:
 The Chelsea facility integrates several processes under one roof. After medical waste is collected at hospitals, labs, nursing homes and doctors' offices, it is delivered to the facility where it is loaded into the CFA. Inside the CFA, waste is treated at temperatures that render it non-infectious, but do not change or break down its physical characteristics. The disinfected material is composed primarily of plastic and paper. Disinfected material then is placed into the recycling system that produces plastic pellets. These pellets can then be used as raw material for plastic injection molding.
 A Cooperative Effort:
 "The Chelsea project also represents a successful partnership among several private and public companies and with government," Frisco said. "The Commonwealth of Massachusetts, which has long been a leader in the `high tech' boom is now gaining recognition as a center for `envirotech' development. The governor's economic development team and the Department of Environment Protection made this opening possible."
 BioMed provides medical waste management services to healthcare providers in major U.S. markets including New York, Philadelphia, Houston, Minneapolis, New Orleans, Buffalo, Rochester and Nashville.
 -0- 7/15/93
 /NOTE TO EDITORS: For additional information on BioMedical Waste Systems free of charge via fax, dial 800-PRO-INFO and use company code 017/
 /CONTACT: Gene Frisco, president and CEO of BioMedical Waste Systems, Inc., 617-556-4033, or Dennis Waite, senior partner, or Mark Harvill, account executive of Financial Relations Board, 312-266-7800, for BioMedical Waste Systems, Inc./
 (BWSI)


CO: BioMedical Waste Systems Inc. ST: Massachusetts IN: HEA SU:

MP-OS -- NY043 -- 1957 07/15/93 12:32 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 15, 1993
Words:508
Previous Article:ISG TECHNOLOGIES INC. ISSUES UPDATE, A NEWSLETTER FOR ISG INVESTORS
Next Article:SEARS ANNOUNCES FLOOD RELIEF EFFORTS
Topics:


Related Articles
AMDL OBTAINS PATENT ALLOWANCE FOR UNIVERSAL-TUMOR MARKER DETECTION SYSTEM; ALSO FILES CONTINUANCE FOR BROADER CLAIMS
BIOMED ANNOUNCES SITE PERMIT FOR CHELSEA, MASS., PLANT; PLANS TO COMPLETE $9.5 MILLION IRB FINANCING
GENETRONICS RECEIVES NOTICES OF ALLOWANCE FOR THREE PROCESS PATENTS AND AN APPARATUS PATENT
MORE DEVELOPMENTS ANNOUNCED BY BION
Chemical Weapons Patents Awarded to Commodore Applied Technologies.
Regenesis Biomedical Receives Two Notices of Allowance From The United States Patent and Trademark Office Protecting Platform Technology.
Regenesis receives two notices of allowance protecting platform technology.
First Patent for High Security Genetic Banking System Issued to First Genetic Trust; Technology Allows Genetic Data To Be Securely Used for Research...
PEAT International Commissions Government-Sponsored Plasma-Based Waste Treatment Facility; - Marks the first time Taiwan committed financial and...
PEAT International Commissions Plasma-Based Waste Treatment Facility Designed Specifically for Onsite Waste Processing.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters